about
STING: infection, inflammation and cancerPattern Recognition Receptors in Cancer Progression and MetastasisHost immune response to infection and cancer: unexpected commonalitiesMicrobiome, inflammation, and cancerDownregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma.The interleukin-1 family: back to the futureThe role of the microbiota in inflammation, carcinogenesis, and cancer therapy.Radiation takes its TollEffect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancerMechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer.Deficiency of the myeloid differentiation primary response molecule MyD88 leads to an early and rapid development of Helicobacter-induced gastric malignancy.Rationale for stimulator of interferon genes-targeted cancer immunotherapy.Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6.Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.Clinical and pathological significance of myeloid differentiation factor 88 expression in human hepatocellular carcinoma tissues.Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis.Diverse roles of STING-dependent signaling on the development of cancerHigh IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity.MyD88 promotes myoblast fusion in a cell-autonomous manner.STING-Dependent Signaling Underlies IL-10 Controlled Inflammatory Colitis.Hydrogen-water ameliorates radiation-induced gastrointestinal toxicity via MyD88's effects on the gut microbiota.MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.IL-1 and IL-1 regulatory pathways in cancer progression and therapy.Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin.Role of Pattern Recognition Receptors in KSHV Infection.Loss of TNFAIP3 enhances MYD88-driven signaling in non-Hodgkin lymphoma
P2860
Q26776009-588B8AEC-1650-4DD6-94FA-AC5006C80F66Q26798034-74A46A0D-B286-48E7-86B2-CB71CF335BC2Q27015410-9FAE97A4-BD21-405A-9539-8D67BDF44534Q27027582-663D3827-CABA-4682-99D3-F6855C6CCED8Q33853103-DE40F86E-D9F6-476F-8410-38DD929D5229Q34391415-2A53E6AB-8442-4A38-B01D-540EC57F716FQ35346303-D8C932A1-ADDD-4F4E-9799-F8A60827FFF7Q36083353-B8EA4069-0780-45DC-8D40-1A6D79C60D37Q36281632-9DA3C4BF-90E5-4821-8A98-F26EB1CDA953Q36827259-4D6ADD1E-047D-4125-B305-25CC4954D91CQ37548248-C7DF09A4-3D51-4F2D-98D8-D852886E8D2BQ39144454-939572E4-A729-41DB-9589-C3770EF563AEQ39476992-E35C8B37-4606-490A-B528-D3CFC2DBACCBQ40163535-08E75903-A7F7-4755-9508-7A0F7AE2CF0FQ40261017-4A5ADEB0-6166-4B6C-9CBB-D7DBE65EA2CBQ40627933-A9F9DA7E-8086-4DE6-8397-07C6402CEDB9Q41140047-99591E88-2EF8-49C6-AB0C-695BFCC58854Q41472534-45A4CFF0-B1DB-4754-97C4-90CE9731E76AQ45330039-2960B642-C861-4228-BB83-6EAB69F35D8EQ47242659-0334D2D7-5200-42FA-8EF6-9C4931AD6607Q47700286-EEE968CA-B015-498E-A97C-54DE86263C34Q51689102-12A9B67F-B5EB-4B9C-BE48-6CAEB707035EQ53179726-B5D055A6-14F2-4150-A913-CE09B90EA589Q53179835-9F724EA3-1B17-41D1-B24F-CBBCC398DF16Q55338587-C732A78D-250E-4642-9EAE-64AEE328A7DEQ57287569-731CC574-8733-44A8-89AB-592E259D0715
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MyD88 and its divergent toll in carcinogenesis.
@en
MyD88 and its divergent toll in carcinogenesis.
@nl
type
label
MyD88 and its divergent toll in carcinogenesis.
@en
MyD88 and its divergent toll in carcinogenesis.
@nl
prefLabel
MyD88 and its divergent toll in carcinogenesis.
@en
MyD88 and its divergent toll in carcinogenesis.
@nl
P2093
P2860
P356
P1433
P1476
MyD88 and its divergent toll in carcinogenesis
@en
P2093
Christophe Cataisson
Giorgio Trinchieri
Rosalba Salcedo
Stuart H Yuspa
P2860
P304
P356
10.1016/J.IT.2013.03.008
P50
P577
2013-05-07T00:00:00Z